Gruppo FarmaImpresa obtains MDR Certification for intra-articular Syringes based on Hyaluronic Acid
Gruppo FarmaImpresa has recently obtained the prestigious MDR (Medical Device Regulation) certification for high molecular weight hyaluronic acid-based intra-articular syringes, adding an important milestone to their portfolio of MDR-compliant CE certifications.
We are thrilled to have embarked on the complex MDR certification process, as it fully reflects our company’s mission to prioritize safety and effectiveness.
This achievement is particularly significant as it places us among the first companies in Italy to obtain MDR certifications for a selection of our substance-based medical devices.
The result is the outcome of a two-year dedicated effort to ensure full compliance of our medical devices with regulatory requirements, aiming to anticipate legislative changes and promote the success of our clients.
Gruppo FarmaImpresa goes beyond being a mere supplier of products and services; we strive to be a true partner, sharing perspectives and projects.
We have successfully developed our processes, involving numerous departments and employees, to ensure full compliance with current regulations.
If your company is seeking an MDR-certified medical device in ready to market line (PJPHARMA) or in private label for the treatment of degenerative and post-traumatic joint conditions, we have a solution for you.
